Caveolin-1, a Key Mediator Across Multiple Pathways in Glioblastoma and an Independent Negative Biomarker of Patient Survival

Glioblastoma (GB) remains an aggressive malignancy with an extremely poor prognosis. Discovering new candidate drug targets for GB remains an unmet medical need. Caveolin-1 (Cav-1) has been shown to act variously as both a tumour suppressor and tumour promoter in many cancers. The implications of Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriconi, Chiara, Civita, Prospero, Neto, Catia, Pilkington, Geoffrey J., Gumbleton, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417742/
https://www.ncbi.nlm.nih.gov/pubmed/34490102
http://dx.doi.org/10.3389/fonc.2021.701933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417742/
https://www.ncbi.nlm.nih.gov/pubmed/34490102
http://dx.doi.org/10.3389/fonc.2021.701933

Ejemplares similares